← Back

Macrogen Inc

Macrogen, Inc. provides genetic and genomic analysis research services in South Korea and internationally. Its offerings include next-generation sequencing (NGS) services such as whole genome, exome, targeted, transcriptome, metagenome, epigenome, and single-cell multi-omics sequencing, as well as whole genome resequencing. The company also provides Sanger sequencing, fragment analysis, clinical diagnostics, personal genome analysis, genetic testing for research purposes, oligo and gene synthesis, and CRISPR design and synthesis materials. Additionally, it offers genetically engineered mice for research, COVID-19 test kits under the Axen name, smart mobile labs for COVID-19 testing, and genetic testing services iD4U and myPETGENE. Founded in 1997, Macrogen is headquartered in Seoul, South Korea.

Price · split & dividend adjusted
News & notes moving 038290.KQ